Mon. May 25th, 2026
Spread the love

A distinct leader  by total assets and gross earnings  in the Nigerian banking industry, First Bank of Nigeria Ltd, a subsidiary of FBN Holdings Plc, is validating its leadership position yet again as it presently accounts for 45 percent of bills payment services on ATM in the nation’s banking industry as at December 2015.

 

As at December 2015, about 275,000 bill payments were made through the bank’s Automated Teller Machines (ATMs) while the value of airtime purchase on all its ATMs was about N3 billion. The bills payment option is one of the features of FirstBank’s ATMs, which also have other unique functional features which include cash transfer, air-time top-up, cash deposit among others.

 

The bills payment option is the non-cash transaction feature on the ATM that makes it easier for customers to pay for bills such as Cable TV subscription, post-paid phone bills, and pre- booked airline tickets.  These transactions can be executed through the Quickteller option on any of the bank’s ATMs.

 

The Transfer feature enables customers to transfer money from their accounts to both intra (within FirstBank) and interbank (other banks) accounts, thereby reducing the queues in the banking hall, save time as well as provide a more convenient option for customers’ money transfer needs.

 

To reach out to more customers and in line with its strategy to drive ease of service in banking, FirstBank is presently leading in the industry as the bank with the highest number of Automated Teller Machines (ATMs) with about 2,700 ATMs deployed across the country, making it the nation’s financial institution with the widest retail footprint.

 

The bank is also currently responsible for over 40 percent of interbank transactions and 27 percent of airtime vending. As active mobile network users in Nigeria are over 151 million and the need to recharge is on the increase, the bank’s ATMs also provide the platform for easy top-up.

 

To further enhance convenience, FirstBank’s ATMs also operate the Cash Deposit function which allows customers to deposit funds without customarily having to enter a banking hall for this transaction. This is a direct testament to its value proposition of putting customers first.

 

Folake Ani-Mumuney, the bank’s spokesperson, said this distinct development was achieved as a result of the bank’s desire to reach out to more people in the country and as part of living true to putting customers at the heart of our business. “FirstBank is positioned to meet the needs of its customers and to reach out to the under banked and unbanked. Our mission is to make banking as convenient for our customers as is obtainable globally”, she said.

 

She said that to aid the use of its ATMs nationwide and for enhanced protection of customers’ funds, the Bank has, in particular, designed innovative and tailored-made financial services products to ease banking transactions. A major product is the FirstBank Verve Debit card, a Naira denominated domestic payment card accepted for payment throughout Nigeria on all electronic channels, including the ATMs.

 

One of the outstanding and unique features of our debit card products is that it is issued in 15 minutes at FirstBank branches. This distinctive feature stands the product out as it saves time and is very easy to obtain. Also, the card, which is accepted nationwide, aside withdrawing of cash, can be used to access value added services including bills payment, airtime recharge, flight and hotel booking among others.

 

The card is Chip & PIN secured for greater protection of customers’ funds, provides extra protection for web based transactions with “Safetoken”, is Naira denominated, and personalized, bearing the customer’s name. It is accepted wherever the Interswitch or Verve logo is displayed and can also be used to perform transactions via the Quickteller services menu on FirstBank ATMs.

The bank also has a Naira denominated international Debit card issued in partnership with MasterCard Worldwide, a card which enables transactions all over the world wherever the MasterCard logo is displayed. The card is accepted worldwide at over 29.4 million merchant locations and can be used for transactions over the WEB or POS as well as cash withdrawals at over 1.8 million ATMs, in over 210 countries. The card is also secured by Chip & PIN technology and is issued within 15 minutes at FirstBank branches.

 

The bank has a VISA Naira Credit Card designed for customers who operate salary accounts within the bank. The card is accepted worldwide for cash withdrawals and purchases on ATMs and POS terminals, and for e-commerce on the Internet done either on desktop computers or mobile devices. The card allows customers a 45-day interest-free period on spent funds and settlement is done in Naira.

 

The bank also has a number of other card products tailored to addressing the varied needs of customers – VISA Debit (Dual currency – denominated in NGN and USD), VISA Prepaid (denominated in NGN and USD), VISA Gold card as well as premium cards-  MasterCard Platinum, and VISA Infinite.

 

To cater for as many customers as possible, the bank’s ATMs are equipped with cardless functionality that makes it easier for non-bank customers to deposit or withdraw money from the ATMs without a Debit card.

 

With FirstBank’s brand proposition – You First, the Bank is committed to put customers at the centre of its business, surpass expectations and deliver the ‘gold standard’ experience at every conceivable touch point.  This underpins the bank’s drive to provide solutions that are not just innovative, but relevant and effective to customers.

 

FirstBank has solidified itself as a brand of fortitude, strength and innovation in the Nigerian financial institution since 1894, sustaining its leadership of the market across all performance indices and channels. At the end of December 2015, FirstBank had deployed a total of 2,749 active ATMs. The Bank’s ATMs dispensed over N2.1 trillion between January and December 2015.

 

By admin

You missed

From Tramadol to Canadian to Exol-5 The New Drug Destroying Nigerian Youths An Investigative Article .From Tramadol to Canadian to Exol-5: The New Drug Destroying Nigerian Youths An Investigative Report on the Shifting Landscape of Substance Abuse in Nigeria Nigeria faces a severe and evolving drug crisis, particularly among its youth. What began with the widespread abuse of Tramadol has progressed through mixtures like “Canadian” to newer pharmaceutical diversions such as Exol-5. This shift reflects deeper issues: easy access to prescription drugs, weak regulation, socioeconomic pressures, and aggressive street-level marketing. NDLEA operations and health studies reveal a public health emergency that threatens an entire generation. Phase 1: The Tramadol Epidemic (2010s–Early 2020s) Tramadol, a synthetic opioid prescribed for moderate to severe pain, became Nigeria’s most notorious street drug. Cheap, potent, and widely smuggled (often from India and other Asian countries), it offered users energy, euphoria, and pain relief — appealing to commercial drivers, laborers, students, and young men seeking confidence or stamina. Scale of the Problem: Millions of tablets seized annually by NDLEA. High prevalence among young males aged 15–35. Linked to increased crime, sexual violence, organ damage (kidney failure, seizures), and mental health breakdowns. Contributed to broader opioid misuse alongside codeine cough syrups. Government responses included tighter import controls and public awareness campaigns, but these only displaced demand to other substances rather than eliminating it. Phase 2: The Rise of “Canadian” (Mid-2020s) “Canadian” or “Canadian Loud” emerged as a popular code for high-grade cannabis (often indica-dominant strains) or cannabis mixed with other synthetics. It gained traction as users sought alternatives or combinations to Tramadol’s effects. This phase marked a move toward imported or locally cultivated premium weed, sometimes laced with stronger chemicals. Youths in urban centers like Lagos, Kano, Jos, and Onitsha embraced it for its perceived “cleaner” high compared to opioids. However, it fueled polydrug use — combining cannabis with opioids, sedatives, or alcohol — amplifying health risks. Phase 3: Exol-5 – The Current Threat (2024–2026) Exol-5 (Benzhexol Hydrochloride / Trihexyphenidyl 5mg), originally a prescription medication for Parkinson’s disease and drug-induced movement disorders, has become the latest pharmaceutical being heavily abused. Why Exol-5? Euphoric Effects: Users report intense euphoria, hallucinations, and a sense of detachment — making it attractive as a cheap “upper” or escape. Accessibility: Sold over-the-counter or on the black market despite being a controlled prescription drug. NDLEA has seized millions of pills in single operations (e.g., 3.1 million pills in Kano in late 2024, and over 5.6 million combined with Tramadol in other busts). Street Names: Exol, Artane, Benzhexol, “Farin Mallam” (in Northern Nigeria). Demographics: Prevalent among youths, laborers, and even psychiatric patients who divert prescriptions. Studies show abuse rates as high as 25% among certain outpatient groups. Health Consequences: Anticholinergic toxicity: Confusion, dry mouth, blurred vision, urinary retention, constipation, and in high doses — delirium, psychosis, seizures, and heart issues. Long-term: Cognitive impairment, addiction, exacerbated mental health disorders. Often mixed with Tramadol, codeine, or cannabis, creating dangerous synergies. In cities like Jos, Exol-5 sits alongside diazepam, Rohypnol, and Tramadol on street markets, easily available to teenagers and young adults. Why This Evolution Continues Supply-Side Failures: Porous borders, corrupt officials, and overproduction of pharmaceuticals enable diversion. Demand Drivers: Unemployment, poverty, peer pressure, trauma, and the pursuit of performance enhancement (e.g., for “hustle” culture). Weak Regulation: Many pharmacies sell restricted drugs without prescriptions. Online and street vendors fill gaps. Displacement Effect: Cracking down on one substance (Tramadol/codeine) pushes users and dealers toward the next available option. NDLEA reports ongoing large seizures, but the problem persists due to high profitability and low risk for mid-level distributors. Broader Impacts on Nigerian Youths Education: Increased dropout rates and poor academic performance. Mental Health: Rising cases of psychosis and depression. Economy: Lost productivity among the working-age population. Crime and Violence: Drug-fueled robberies, cultism, and family breakdowns. Public Health System Strain: Overburdened hospitals treating overdoses and chronic complications. Young people aged 15–39 remain the hardest hit, with national surveys showing drug use prevalence significantly above global averages. What Must Be Done Stronger Enforcement: Consistent prosecution of corrupt enablers and large-scale traffickers. Regulation: Crackdown on rogue pharmacies and better tracking of prescription drugs. Prevention & Rehabilitation: School programs, community outreach, and expanded treatment centers (currently woefully inadequate). Economic Alternatives: Address root causes like youth unemployment. Public Awareness: Honest campaigns highlighting real dangers of “Exol-5” and similar drugs. Conclusion From Tramadol’s opioid grip to “Canadian” cannabis culture and now Exol-5’s anticholinergic highs, Nigeria’s drug crisis is mutating faster than responses can contain it. Exol-5 represents the dangerous new frontier — a legitimate medicine turned youth destroyer due to misuse and greed. Without urgent, multi-layered intervention — combining supply disruption, demand reduction, and socioeconomic support — an entire generation risks being lost to addiction. The time for half-measures is over. Nigeria’s future depends on winning this fight.